• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名神经母细胞瘤患者血浆和脑脊液中的超滤液及总铂含量

Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.

作者信息

DeGregorio M W, King O Y, Holleran W M, Wilbur B J, Cadman E C, Deisseroth A B, Wilbur J R

出版信息

Cancer Treat Rep. 1985 Dec;69(12):1441-2.

PMID:4075318
Abstract

Ultrafiltrate and total plasma and cerebrospinal fluid (CSF) platinum concentrations were examined in a patient with neuroblastoma following a 2-hour infusion of 120 mg/m2 of cisplatin. Total plasma platinum was 93.4% bound, while the ultrafiltrate of plasma accounted for the remaining 6.6%. The CSF ultrafiltrate resulted in equivalent concentrations of platinum to total CSF platinum. CSF concentrations were 2.9% of the total plasma platinum and 43.5% of the ultrafiltrate plasma platinum 2 hours after the end of the infusion.

摘要

在一名神经母细胞瘤患者静脉输注120mg/m²顺铂2小时后,检测了其超滤液、全血浆及脑脊液(CSF)中的铂浓度。血浆中93.4%的铂呈结合状态,而血浆超滤液中的铂占其余的6.6%。脑脊液超滤液中的铂浓度与脑脊液总铂浓度相当。输注结束2小时后,脑脊液中的铂浓度为血浆总铂浓度的2.9%,为血浆超滤液铂浓度的43.5%。

相似文献

1
Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma.一名神经母细胞瘤患者血浆和脑脊液中的超滤液及总铂含量
Cancer Treat Rep. 1985 Dec;69(12):1441-2.
2
Peak cerebrospinal fluid platinum levels in a patient with ependymoma: evaluation of two different methods of cisplatin administration.室管膜瘤患者脑脊液中铂的峰值水平:两种不同顺铂给药方法的评估
Cancer Treat Rep. 1986 Dec;70(12):1437-8.
3
[Pharmacokinetics of plasma and cerebrospinal fluid cisplatin in patients with malignant glioma and metastatic brain tumor after selective intraarterial or intravenous and intracarotid administration of etoposide and cisplatin].[恶性胶质瘤和转移性脑肿瘤患者在选择性动脉内或静脉及颈动脉给予依托泊苷和顺铂后血浆和脑脊液中顺铂的药代动力学]
No Shinkei Geka. 1994 Jan;22(1):35-42.
4
Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates.非人类灵长类动物中静脉注射奥沙利铂、顺铂和卡铂的血浆及脑脊液药代动力学
Clin Cancer Res. 2005 Feb 15;11(4):1669-74. doi: 10.1158/1078-0432.CCR-04-1807.
5
Kinetics of cisplatin in an anuric patient undergoing hemofiltration dialysis.顺铂在接受血液滤过透析的无尿患者体内的动力学
Cancer Treat Rep. 1981 Jul-Aug;65(7-8):665-8.
6
Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion.顺二氯二氨合铂II在儿童快速输注后的药代动力学研究。
Biomedicine. 1981 Dec;34(3):146-53.
7
Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II).顺二氯二氨铂(II)治疗患者肝肠循环的药代动力学证据。
Res Commun Chem Pathol Pharmacol. 1980 May;28(2):319-28.
8
[Pharmacokinetics of cis-dichlorodiammineplatinum (II)].
Gan To Kagaku Ryoho. 1982 Apr;9(4):632-7.
9
Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.用于测定人血浆超滤液中顺铂、卡铂和奥沙利铂来源铂的灵敏电感耦合等离子体质谱分析法。
J Mass Spectrom. 2006 Sep;41(9):1186-94. doi: 10.1002/jms.1087.
10
Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.儿童顺铂持续或重复长时间输注:一项关于耳毒性、铂浓度及标准血清参数的前瞻性研究。
Pediatr Blood Cancer. 2006 Aug;47(2):183-93. doi: 10.1002/pbc.20673.

引用本文的文献

1
Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung.铂类辅助化疗治疗早期肺鳞癌和腺癌的生存分析比较。
Cancer Med. 2022 May;11(10):2067-2078. doi: 10.1002/cam4.4570. Epub 2022 Mar 10.
2
Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.铂类抗肿瘤药物向中枢神经系统的直接递送:一项毒性和超微结构研究。
Cancer Chemother Pharmacol. 1993;31(6):449-54. doi: 10.1007/BF00685034.
3
A critique of the role of the blood-brain barrier in the chemotherapy of human brain tumors.
血脑屏障在人类脑肿瘤化疗中作用的批判性分析
J Neurooncol. 1994;20(2):121-39. doi: 10.1007/BF01052723.
4
Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.豚鼠静脉注射顺铂后其外淋巴液和脑脊液中的分布情况。
Cancer Chemother Pharmacol. 1995;36(1):83-6. doi: 10.1007/BF00685738.
5
Permeability change and brain tissue damage after intracarotid administration of cisplatin studied by double-tracer autoradiography in rats.
J Neurooncol. 1995;24(3):229-40. doi: 10.1007/BF01052839.
6
Pharmacokinetics of cisplatin in patients receiving interleukin-2-containing treatment regimens.接受含白细胞介素-2治疗方案的患者中顺铂的药代动力学。
Cancer Chemother Pharmacol. 1989;24(2):135-6. doi: 10.1007/BF00263136.
7
Platinum-based chemotherapy for recurrent CNS tumours in young patients.铂类化疗用于年轻患者复发性中枢神经系统肿瘤
J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):722-5. doi: 10.1136/jnnp.54.8.722.